200 related articles for article (PubMed ID: 30128034)
1. Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice.
Kumar V; Mundra V; Peng Y; Wang Y; Tan C; Mahato RI
Theranostics; 2018; 8(15):4033-4049. PubMed ID: 30128034
[No Abstract] [Full Text] [Related]
2. Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer.
Kumar V; Mondal G; Slavik P; Rachagani S; Batra SK; Mahato RI
Mol Pharm; 2015 Apr; 12(4):1289-98. PubMed ID: 25679326
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and Biodistribution of GDC-0449 Loaded Micelles in Normal and Liver Fibrotic Mice.
Dutta R; Kumar V; Peng Y; Evande RE; Grem JL; Mahato RI
Pharm Res; 2017 Mar; 34(3):564-578. PubMed ID: 27995525
[TBL] [Abstract][Full Text] [Related]
4. Micelle Mixtures for Coadministration of Gemcitabine and GDC-0449 To Treat Pancreatic Cancer.
Karaca M; Dutta R; Ozsoy Y; Mahato RI
Mol Pharm; 2016 Jun; 13(6):1822-32. PubMed ID: 26981724
[TBL] [Abstract][Full Text] [Related]
5. ROS-Responsive Polymeric Micelles for Triggered Simultaneous Delivery of PLK1 Inhibitor/miR-34a and Effective Synergistic Therapy in Pancreatic Cancer.
Xin X; Lin F; Wang Q; Yin L; Mahato RI
ACS Appl Mater Interfaces; 2019 Apr; 11(16):14647-14659. PubMed ID: 30933478
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution of Self-Assembling Polymer-Gemcitabine Conjugate after Systemic Administration into Orthotopic Pancreatic Tumor Bearing Mice.
Kattel K; Mondal G; Lin F; Kumar V; Mahato RI
Mol Pharm; 2017 May; 14(5):1365-1372. PubMed ID: 27798825
[TBL] [Abstract][Full Text] [Related]
7. The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis.
Kumar V; Dong Y; Kumar V; Almawash S; Mahato RI
Theranostics; 2019; 9(25):7537-7555. PubMed ID: 31695785
[No Abstract] [Full Text] [Related]
8. Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Cancer Growth and Metastasis.
Almawash SA; Mondal G; Mahato RI
Pharm Res; 2018 Jan; 35(1):17. PubMed ID: 29305793
[TBL] [Abstract][Full Text] [Related]
9. Polymeric micelles and nanoemulsions as drug carriers: Therapeutic efficacy, toxicity, and drug resistance.
Gupta R; Shea J; Scafe C; Shurlygina A; Rapoport N
J Control Release; 2015 Aug; 212():70-7. PubMed ID: 26091919
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis.
Kumar V; Mondal G; Dutta R; Mahato RI
Biomaterials; 2016 Jan; 76():144-56. PubMed ID: 26524535
[TBL] [Abstract][Full Text] [Related]
11. EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer.
Mondal G; Almawash S; Chaudhary AK; Mahato RI
Mol Pharm; 2017 Sep; 14(9):3121-3133. PubMed ID: 28719220
[TBL] [Abstract][Full Text] [Related]
12. EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer.
Mondal G; Kumar V; Shukla SK; Singh PK; Mahato RI
Biomacromolecules; 2016 Jan; 17(1):301-13. PubMed ID: 26626700
[TBL] [Abstract][Full Text] [Related]
13. Combined Delivery of Let-7b MicroRNA and Paclitaxel via Biodegradable Nanoassemblies for the Treatment of KRAS Mutant Cancer.
Dai X; Fan W; Wang Y; Huang L; Jiang Y; Shi L; Mckinley D; Tan W; Tan C
Mol Pharm; 2016 Feb; 13(2):520-33. PubMed ID: 26636714
[TBL] [Abstract][Full Text] [Related]
14. Nanoformulation design and therapeutic potential of a novel tubulin inhibitor in pancreatic cancer.
Bhattarai RS; Kumar V; Romanova S; Bariwal J; Chen H; Deng S; Bhatt VR; Bronich T; Li W; Mahato RI
J Control Release; 2021 Jan; 329():585-597. PubMed ID: 33010334
[TBL] [Abstract][Full Text] [Related]
15. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
[TBL] [Abstract][Full Text] [Related]
16. Poly(ethylene glycol)-block-poly(2-methyl-2-benzoxycarbonyl-propylene carbonate) micelles for rapamycin delivery: in vitro characterization and biodistribution.
Lu W; Li F; Mahato RI
J Pharm Sci; 2011 Jun; 100(6):2418-29. PubMed ID: 21264854
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.
Asem H; Zhao Y; Ye F; Barrefelt Å; Abedi-Valugerdi M; El-Sayed R; El-Serafi I; Abu-Salah KM; Hamm J; Muhammed M; Hassan M
J Nanobiotechnology; 2016 Dec; 14(1):82. PubMed ID: 27993139
[TBL] [Abstract][Full Text] [Related]
18. Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution.
Aliabadi HM; Brocks DR; Lavasanifar A
Biomaterials; 2005 Dec; 26(35):7251-9. PubMed ID: 16005061
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential of OMe-PS-miR-29b1 for Treating Liver Fibrosis.
Kumar V; Kumar V; Luo J; Mahato RI
Mol Ther; 2018 Dec; 26(12):2798-2811. PubMed ID: 30287074
[TBL] [Abstract][Full Text] [Related]
20. Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer.
Wen D; Peng Y; Lin F; Singh RK; Mahato RI
Cancer Res; 2017 Jun; 77(12):3244-3254. PubMed ID: 28428276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
